Blinding, or masking, is used to prevent bias in the assessment of outcomes. In a double-blind study, both the researchers and the participants are unaware of which group the participants are in. This helps to eliminate biases that could arise from the expectations or behaviors of either the researchers or the participants. Blinding is particularly important in cancer research due to the potential for subjective interpretation of results.
